Correlation Between Kura Oncology and Erasca

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kura Oncology and Erasca at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kura Oncology and Erasca into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kura Oncology and Erasca Inc, you can compare the effects of market volatilities on Kura Oncology and Erasca and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kura Oncology with a short position of Erasca. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kura Oncology and Erasca.

Diversification Opportunities for Kura Oncology and Erasca

0.05
  Correlation Coefficient

Significant diversification

The 3 months correlation between Kura and Erasca is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Kura Oncology and Erasca Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Erasca Inc and Kura Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kura Oncology are associated (or correlated) with Erasca. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Erasca Inc has no effect on the direction of Kura Oncology i.e., Kura Oncology and Erasca go up and down completely randomly.

Pair Corralation between Kura Oncology and Erasca

Given the investment horizon of 90 days Kura Oncology is expected to under-perform the Erasca. In addition to that, Kura Oncology is 1.53 times more volatile than Erasca Inc. It trades about -0.21 of its total potential returns per unit of risk. Erasca Inc is currently generating about 0.01 per unit of volatility. If you would invest  259.00  in Erasca Inc on October 1, 2024 and sell it today you would lose (5.00) from holding Erasca Inc or give up 1.93% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy97.62%
ValuesDaily Returns

Kura Oncology  vs.  Erasca Inc

 Performance 
       Timeline  
Kura Oncology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kura Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Erasca Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Erasca Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Erasca is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Kura Oncology and Erasca Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kura Oncology and Erasca

The main advantage of trading using opposite Kura Oncology and Erasca positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kura Oncology position performs unexpectedly, Erasca can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Erasca will offset losses from the drop in Erasca's long position.
The idea behind Kura Oncology and Erasca Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
FinTech Suite
Use AI to screen and filter profitable investment opportunities